Everest Medicines Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Aug '25 Aug 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Market Capitalization	24,547	15,592	6,698	5,375	10,326	19,851	Upgrade
Market Cap Growth	132.78%	132.78%	24.63%	-47.95%	-47.98%	-	Upgrade
Enterprise Value	23,453	13,630	4,306	3,712	6,099	22,544	Upgrade
Last Close Price	69.95	48.40	20.90	17.38	34.80	67.70	Upgrade
PS Ratio	32.64	20.73	48.28	371.66	155778.93	-	Upgrade
PB Ratio	5.66	3.60	1.22	0.84	1.43	2.44	Upgrade
P/TBV Ratio	12.69	8.06	2.49	1.45	2.46	3.46	Upgrade
EV/Sales Ratio	31.19	18.12	31.04	256.65	92015.48	-	Upgrade
Debt / Equity Ratio	0.14	0.14	0.11	0.10	0.09	0.07	Upgrade
Asset Turnover	0.13	0.13	0.02	0.00	0	-	Upgrade
Inventory Turnover	10.77	10.77	2.25	0.77	-	-	Upgrade
Quick Ratio	2.51	2.51	7.55	3.84	9.84	24.04	Upgrade
Current Ratio	2.54	2.54	7.63	3.92	9.95	24.06	Upgrade
Return on Equity (ROE)	-23.04%	-23.04%	-15.90%	-4.28%	-15.84%	-189.24%	Upgrade
Return on Assets (ROA)	-9.09%	-9.09%	-8.59%	-13.24%	-9.29%	-8.94%	Upgrade
Return on Capital (ROIC)	-9.60%	-9.60%	-9.10%	-13.94%	-9.56%	-9.31%	Upgrade
Earnings Yield	-4.51%	-7.11%	-13.89%	-5.20%	-11.99%	-33.85%	Upgrade
FCF Yield	-3.23%	-5.08%	-14.58%	-31.80%	-9.98%	-2.88%	Upgrade
Buyback Yield / Dilution	-2.51%	-2.51%	-5.18%	-1.49%	-243.61%	-1532.82%	Upgrade

Updated Aug 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.